You are using an older browser version. Please use a supported version for the best MSN experience.

MHRA: Benefits of AstraZeneca vaccine outweight risks for 'vast majority' of people

The benefits of the AstraZeneca vaccine outweigh the risks for the “vast majority” of people after cases of blood clots were detected in an “extremely small” number of people, Dr June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency said.
image beaconimage beaconimage beacon